Style de citation APA

Nucera, C. (2019). A novel combined targeted therapy with bromodomain antagonist and MEK inhibitor in anaplastic thyroid cancer. Oncotarget.

Style de citation Chicago

Nucera, Carmelo. "A Novel Combined Targeted Therapy With Bromodomain Antagonist and MEK Inhibitor in Anaplastic Thyroid Cancer." Oncotarget 2019.

Style de citation MLA

Nucera, Carmelo. "A Novel Combined Targeted Therapy With Bromodomain Antagonist and MEK Inhibitor in Anaplastic Thyroid Cancer." Oncotarget 2019.

Attention : ces citations peuvent ne pas être correctes à 100%.